Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04173611Phase 1Terminated
Phase 1, randomised, double-blind trial of liposomal bupivacaine in pain (3 arms), sponsored by Pacira BioSciences. Primary endpoints: Area under the plasma concentration-versus-time curve, Maximum plasma concentration and 4 more. Started Jun 2020; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04173611.